Clinical trial NCT03979209 - References

Chronic Rhinosinusitis (Diagnosis) — Potential for Cortisol Suppression With the Use of High Volume Nasal Mometasone Irrigations in Varying Dosages.

Citation(s)

•   Brannan, M
  D., Seiberling, M., Cutler, D. L., Cuss, F. M., & Affrime, M. B. (1996, January). Lack of systemic activity with intranasal mometasone furoate. In JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (Vol. 97, No. 1, pp. 62-62). 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318: MOSBY-YEAR BOOK INC.
•   Brattsand, R
  What factors determine anti-inflammatory activity and selectivity of inhaled steroids? Eur. Respir. Rev. 1997, 7, 356- 361.
•   Corren J
  Intranasal corticosteroids for allergic rhinitis: how do different agents compare? J Allergy Clin Immunol. 1999 Oct;104(4 Pt 1):S144-9. Review.
•   Davies RJ, Nelson HS
  Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis. Clin Ther. 1997 Jan-Feb;19(1):27-38; discussion 2-3. Review.
•   Derendorf H, Meltzer EO
  Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008 Oct;63(10):1292-300. doi: 10.1111/j.1398-9995.2008.01750.x. Review.
•   Harvey RJ, Debnath N, Srubiski A, Bleier B, Schlosser RJ
  Fluid residuals and drug exposure in nasal irrigation. Otolaryngol Head Neck Surg. 2009 Dec;141(6):757-61. doi: 10.1016/j.otohns.2009.09.006.
•   Hochhaus G
  Pharmacokinetic/pharmacodynamic profile of mometasone furoate nasal spray: potential effects on clinical safety and efficacy. Clin Ther. 2008 Jan;30(1):1-13. doi: 10.1016/j.clinthera.2008.01.005. Review.
•   Lipworth BJ, Jackson CM
  Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf. 2000 Jul;23(1):11-33. Review.
•   Nasonex(R) [package insert]
  Whitehouse Station, NJ: Merk & CO.,INC; 1997.
•   Pulmicort(R) [package insert]
  Wilmington, DE: AstraZeneca; 2000.
•   Sastre J, Mosges R
  Local and systemic safety of intranasal corticosteroids. J Investig Allergol Clin Immunol. 2012;22(1):1-12. Review.
•   Smith KA, French G, Mechor B, Rudmik L
  Safety of long-term high-volume sinonasal budesonide irrigations for chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016 Mar;6(3):228-32. doi: 10.1002/alr.21700. Epub 2016 Jan 11.
•   Soudry E, Wang J, Vaezeafshar R, Katznelson L, Hwang PH
  Safety analysis of long-term budesonide nasal irrigations in patients with chronic rhinosinusitis post endoscopic sinus surgery. Int Forum Allergy Rhinol. 2016 Jun;6(6):568-72. doi: 10.1002/alr.21724. Epub 2016 Feb 16.

Potential for Cortisol Suppression With the Use of High Volume Nasal Mometasone Irrigations in Varying Dosages.

Details for clinical trial NCT03979209